U.S., Oct. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07217392) titled 'Left Bundle Branch Area Pacing (LBBAP) PMCF Study' on Oct. 14.
Brief Summary: The objective of this study is to evaluate the safety and effectiveness of LBBA pacing/sensing in patients implanted with the Tendril STS 2088TC or UltiPace LPA1231 lead through 6 months post-implant.
Study Start Date: July 24
Study Type: INTERVENTIONAL
Condition:
Bradycardia
Right Ventricular Pacing
Heart Failure
Atrial Fibrillation (AF)
Cardiac Disease
Left Bundle Branch Area Pacing
Conduction System Pacing
Intervention:
DEVICE: LBBAP lead
The lead is bipolar, steroid-eluting, active fixation, MR Conditional, implantable pacing leads that can be p...